These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 12022083

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical studies on gabapentin in Switzerland].
    Shokry A.
    Praxis (Bern 1994); 1996 Jan 23; 85(4):94-8. PubMed ID: 8578060
    [Abstract] [Full Text] [Related]

  • 3. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.
    Chadwick DW, Anhut H, Greiner MJ, Alexander J, Murray GH, Garofalo EA, Pierce MW.
    Neurology; 1998 Nov 23; 51(5):1282-8. PubMed ID: 9818846
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Gabapentin in children and adolescents with epilepsy].
    Herranz JL.
    Rev Neurol; 1998 Nov 23; 34(4):384-7. PubMed ID: 12022057
    [Abstract] [Full Text] [Related]

  • 6. [Gabapentin in 50 patients with epilepsy].
    Gracia-Fleta F, Medrano-Martínez V, Castaño-Pérez MD, Hernández-Lorido R, Mañes R.
    Rev Neurol; 1998 Nov 23; 32(1):45-9. PubMed ID: 11293098
    [Abstract] [Full Text] [Related]

  • 7. [Gabapentin as adjuvant therapy in the treatment of refractory partial epilepsy].
    Tomović M, Ilić T, Mihajlović M, Jovicić A.
    Vojnosanit Pregl; 1999 Nov 23; 56(2):151-6. PubMed ID: 10437420
    [Abstract] [Full Text] [Related]

  • 8. [Trials with gabapentin monotherapy in patients with complex partial or secondary generalized seizures].
    Pierce MW, Shokry A.
    Praxis (Bern 1994); 1997 Sep 10; 86(37):1430-1. PubMed ID: 9381042
    [Abstract] [Full Text] [Related]

  • 9. Clinical efficacy and safety of gabapentin.
    Ramsay RE.
    Neurology; 1994 Jun 10; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537
    [Abstract] [Full Text] [Related]

  • 10. Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. GREAT Study Investigators Group. Gabapentin in Refractory Epilepsy Add-on Treatment.
    Lindberger M, Alenius M, Frisén L, Johannessen SI, Larsson S, Malmgren K, Tomson T.
    Epilepsia; 2000 Oct 10; 41(10):1289-95. PubMed ID: 11051124
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gabapentin in refractory partial epilepsy--a trial in India.
    Dixit SN, Jain S, Padma MV, Maheshwari MC.
    Acta Neurol Scand; 1996 Oct 10; 93(2-3):85-7. PubMed ID: 8741123
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerance of long-term, high-dose gabapentin: additional observations.
    Handforth A, Treiman DM.
    Epilepsia; 1994 Oct 10; 35(5):1032-7. PubMed ID: 7925148
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Gabapentin for drug-resistant partial epilepsy.
    Marson AG, Kadir ZA, Hutton JL, Chadwick DW.
    Cochrane Database Syst Rev; 2000 Oct 10; (2):CD001415. PubMed ID: 10796785
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.